220 related articles for article (PubMed ID: 809959)
1. Correlation in hemodialysis patients and renal allograft recipients between percent T lymphocytes in peripheral blood and in vitro lymphocyte responses to nonspecific mitogenic agents.
Sengar DP; Rashid A; Harris JE
Acta Haematol; 1975; 54(3):159-64. PubMed ID: 809959
[TBL] [Abstract][Full Text] [Related]
2. 5-bromodeoxyuridine-light inactivation of human lymphocytes stimulated mitogens and allogeneic cells: evidence for distinct T-lymphocyte subsets.
Touraine JL; Touraine F; Hadden JW; Hadden EM; Good RA
Int Arch Allergy Appl Immunol; 1976; 52(1-4):105-17. PubMed ID: 1087917
[TBL] [Abstract][Full Text] [Related]
3. An assessment of cell-mediated immunity in acute allograft rejection in man. A prospective study.
Buckingham JM; Ritts RE; Woods JE; Ilstrup DM
Mayo Clin Proc; 1977 Feb; 52(2):101-5. PubMed ID: 344999
[TBL] [Abstract][Full Text] [Related]
4. Mitogens of B and T cells from peripheral blood in rheumatoid arthritis.
Clot J; Mathieu O; Sany J; Serre H
Rheumatology; 1975; 6():199-208. PubMed ID: 1081725
[TBL] [Abstract][Full Text] [Related]
5. Discrepancy between PHA responsiveness and quantitative estimates of T-cell numbers in human peripheral blood during chronic renal failure and immunosuppression after transplantation.
Lopez C; Simmons RL; Touraine JL; Park BH; Kiszkiss DF; Najarian JS; Good RA
Clin Immunol Immunopathol; 1975 May; 4(1):135-42. PubMed ID: 1092496
[No Abstract] [Full Text] [Related]
6. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect.
Kurz P; Köhler H; Meuer S; Hütteroth T; Meyer zum Büschenfelde KH
Kidney Int; 1986 Jun; 29(6):1209-14. PubMed ID: 3489122
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the active thymus derived rosette forming cells in renal allograft survival: a preliminary report.
Kerman RH; Ing TS; Hano JE; Geis WP
Surgery; 1977 Nov; 82(5):607-12. PubMed ID: 335551
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B surface antigen (HBsAg) infection in a hemodialysis unit. II. Factors affecting host immune response to HBsAg.
Sengar DP; Rashid A; McLeish WA; Harris JE; Couture RA; Sutherland M
Can Med Assoc J; 1975 Nov; 113(10):945-8. PubMed ID: 1104126
[TBL] [Abstract][Full Text] [Related]
9. T mediated immunity in patients undergoing periodic hemodialysis.
Piazza I; Alibrandi F; Semenzato G; Battistella L; Amadori G; Gasparotto G
Boll Ist Sieroter Milan; 1978 Nov; 57(5):631-6. PubMed ID: 314813
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte subpopulations in uremics and in transplanted patients.
Krzymanski M; Quadracci L; Ringdén O; Lundgren G
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):37-40. PubMed ID: 781816
[TBL] [Abstract][Full Text] [Related]
11. Total and active T cell dynamics in renal allograft recipients.
Kerman RH; Geis WP
Surgery; 1976 Apr; 79(4):398-407. PubMed ID: 769220
[TBL] [Abstract][Full Text] [Related]
12. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
13. Responses of enriched populations of feline T and B lymphocytes to mitogen stimulation.
Taylor DW; Siddiqui WA
Am J Vet Res; 1977 Dec; 38(12):1969-71. PubMed ID: 304325
[TBL] [Abstract][Full Text] [Related]
14. [Cellular immunity in dialysis patients using the lymphocyte transformation test (LTT) in comparison to conservatively treated patients with chronic terminal renal failure].
Meissner S; Schwenke H; Witzel E; Achenbach H
Z Urol Nephrol; 1986 Apr; 79(5):277-86. PubMed ID: 3526744
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of human T lymphocytes to bind sheep erythrocytes and mitogenic responses of their subpopulations.
Sasaki M; Sekizawa T; Takahashi H; Abo T; Kumagai K
J Immunol; 1975 Dec; 115(6):1509-14. PubMed ID: 1081102
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of human peripheral blood lymphocytes by periodate, galactose oxidase, soybean agglutinin, and peanut agglutinin: differential effects of adherent cells.
Novogrodsky A; Stenzel KH; Rubin AL
J Immunol; 1977 Mar; 118(3):852-7. PubMed ID: 191527
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells.
Roenhorst HW; Beelen JM; Middeldorp JM; Schirm J; Tegzess AM; The TH
Clin Exp Immunol; 1985 Jul; 61(1):72-9. PubMed ID: 2994923
[TBL] [Abstract][Full Text] [Related]
18. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
19. Suppressor cell activity in a male infant with T-and B-lymphocyte dysfunction treated with thymosin.
Hanson LA; Lindholm L; Carlsson B; Fasth A; Fälström SP; Wadsworth C; Värendh G
Scand J Immunol; 1976; 5(10):1227-31. PubMed ID: 1087748
[TBL] [Abstract][Full Text] [Related]
20. Studies on lymphocyte subpopulations and cell-mediated immunity in patients with chronic renal failure.
Park K; Ha SK; Han DS
Yonsei Med J; 1988; 29(2):109-16. PubMed ID: 2975434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
